Home > Research > Publications & Outputs > A reliable auto-robust analysis of blood smear ...


Text available via DOI:

View graph of relations

A reliable auto-robust analysis of blood smear images for classification of microcytic hypochromic anemia using gray level matrices and gabor feature bank

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • B. Azam
  • S.U. Rahman
  • M. Irfan
  • M. Awais
  • O.M. Alshehri
  • A. Saif
  • M.H. Nahari
  • M.H. Mahnashi
Article number1040
<mark>Journal publication date</mark>17/09/2020
Issue number9
Number of pages16
Publication StatusPublished
<mark>Original language</mark>English


Accurate blood smear quantification with various blood cell samples is of great clinical importance. The conventional manual process of blood smear quantification is quite time consuming and is prone to errors. Therefore, this paper presents automatic detection of the most frequently occurring condition in human blood-microcytic hyperchromic anemia-which is the cause of various life-threatening diseases. This task has been done with segmentation of blood contents, i.e., Red Blood Cells (RBCs), White Blood Cells (WBCs), and platelets, in the first step. Then, the most influential features like geometric shape descriptors, Gray Level Co-occurrence Matrix (GLCM), Gray Level Run Length Matrix (GLRLM), and Gabor features (mean squared energy and mean amplitude) are extracted from each of the RBCs. To discriminate the cells as hypochromic microcytes among other RBC classes, scanning is done at angles (0°, 45°, 90°, and 135°). To achieve high-level accuracy, Adaptive Synthetic (AdaSyn) sampling for imbalance learning is used to balance the datasets and locality sensitive discriminant analysis (LSDA) technique is used for feature reduction. Finally, upon using these features, classification of blood cells is done using the multilayer perceptual model and random forest learning algorithms. Performance in terms of accuracy was 96%, which is better than the performance of existing techniques. The final outcome of this work may be useful in the efforts to produce a cost-effective screening scheme that could make inexpensive screening for blood smear analysis available globally, thus providing early detection of these diseases. © 2020 by the authors.